Financial Release
Home  >  Investors  >  Financial Release



Items

Amount for the

current period

Amount for the

same period

last year


Change (%)

Operating income

171,501,338,490

136,097,978,018

26.01

Operating costs

151,070,863,441

120,582,627,749

25.28

Taxes and surcharges

2,499,195,383

1,874,141,394

33.35

Selling expenses

427,684,618

574,433,782

-25.55

Administrative expenses

3,845,610,597

3,689,326,869

4.24

Research and development expenses

582,514,953

476,341,941

22.29

Financial expenses

1,784,243,603

1,466,849,459

21.64

Investment (losses)/income

-522,067,721

34,406,224

Not applicable

Share of profits of associates and joint ventures

209,744,927

96,011,495

118.46

Gains/(Losses) on changes in fair value

342,356,736

-59,752,112

Not applicable

Credit impairment gains/(losses)

130,622,540

-65,619,609

Not applicable

Impairment losses on assets

-357,114,009

-368,381,596

Not applicable

Gains/(Losses) on disposal of non-current assets

12,407,033

-23,675,053

Not applicable

Non-operating income

138,757,205

50,080,938

177.07

Non-operating expenses

532,472,561

317,876,334

67.51

Net profit attributable to non-controlling interests

1,949,485,040

776,947,319

150.92

Changes in fair value of other equity instrument   investments

2,183,173,385

1,146,766,336

90.38

Hedging costs – forward elements

5,617,436

-65,505,914

Not applicable

Exchange differences arising from translation of   financial statements denominated in foreign currencies

-872,186,733

123,196,019

Not applicable

Net cash flows from operating activities

14,268,403,423

10,665,557,013

33.78

Net cash flows used in investing activities

-29,174,439,163

-14,102,830,060

Not applicable

Net cash flows from/(used in) financing activities

20,928,195,130

-325,810,301

Not applicable